Lorlatinib Continuation Study

National Taiwan University Hospital, Taipei

CHU de Rennes - Hôpital Pontchaillou, Rennes

Institut Gustave Roussy, Villejuif

Beijing Chest Hospital, Capital Medical University, Beijing

University Cancer Hospital, Beijing

Beijing Cancer Hospital, Beijing

Beijing Chest Hospital, Capital Medical University, Beijing

National University Hospital, Singapore

Jilin Cancer Hospital, Changchun

The first hospital of jilin university, Changchun

Jilin Cancer Hospital, Changchun

National Cancer Centre Singapore, Singapore

National Cancer Centre Singapore, Singapore

Shanghai Chest Hospital, Shanghai

Fudan University Shanghai Cancer Center, Shanghai

General Hospital of Eastern Theater Command, Nanjing

The First affiliated Hospital of Anhui Medical University, Hefei

The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou

Sir Run Shaw Hospital, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou

Fujian Cancer Hospital, Fuzhou

Bhakti Vedanta Hospital & Research Institute, Thane/Mumbai

Bhaktivedanta Hospital & Research Institute, Thāne

Hunan Cancer Hospital, Changsha

Guangdong Provincial People's Hospital, Guangzhou

Healthcare Global Enterprises, Bengaluru

Sichuan Cancer Hospital, Chengdu

Sichuan Cancer Hospital, Chengdu

The Second Affiliated Hospital of PLA Air Force Medical University, Xi'an

UC Irvine Health, Orange

Aichi Cancer Center Hospital, Nagoya

Hospital Vall D´Hebron, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona